COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,649 Articles (22,913 medRxiv, 8,736 bioRxiv)

Most recent first Previous |  Page 1391: Articles 13901-13910  | Next

Preventable deaths from SARS-CoV-2 in England and Wales: a systematic analysis of coroners case reports from the COVID-19 pandemic
Swift, B., Heneghan, C., Aronson, J. K., Howard, D., Richards, G. C.
10.1101/2021.07.15.21260589 — Posted: 2021-07-23
Increase in ventilatory ratio indicates progressive alveolar damage and suggests poor prognosis in severe COVID-19: A single-center retrospective observational study.
Kaku, N., Nakagama, Y., Shirano, M., Shinomiya, S., Shimazu, K., Yamazaki, K., Maehata, Y., Morita, R., Nitahara, Y., Yamamoto, H., Mizobata, Y., Kido, Y.
10.1101/2021.07.20.21260754 — Posted: 2021-07-22
Surveillance of seasonal respiratory viruses among Chilean patients during the COVID-19 pandemic
Alonso-Palomares, L. A., Caceres, J., Tapia, R., Aguilera-Cortes, P., Valenzuela, S., Valiente-Echeverria, F., Soto-Rifo, R., Gaggero, A., Barriga, G. P.
10.1101/2021.07.16.21260648 — Posted: 2021-07-22
Does COVID-19 vaccination improve mental health? A difference-in-difference analysis of the UnderstandingCoronavirus in America study
Koltai, J., Raifman, J., Bor, J., McKee, M., Stuckler, D.
10.1101/2021.07.19.21260782 — Posted: 2021-07-22
Typically asymptomatic but with robust antibody formation: Childrens unique humoral immune response to SARS-CoV-2
Renk, H., Dulovic, A., Becker, M., Fabricius, D., Zernickel, M., Junker, D., Seidel, A., Gross, R., Hilger, A., Bode, S., Fritsch, L., Frieh, P., Haddad, A., Goerne, T., Remppis, J., Ganzenmueller, T., Dietz, A., Huzly, D., Hengel, H., Kaier, K., Weber, S., Jacobsen, E.-M., Kaiser, P., Traenkle, B., Rothbauer, U., Stich, M., Toenshoff, B., Hoffmann, G. F., Mueller, B., Jahrsdoerfer, B., Ludwig, C., Schrezenmeier, H., Peter, A., Hoerber, S., Iftner, T., Muench, J., Stamminger, T., Wolkewitz, M., Engel, C., Rizzi, M., Gross, H.-J., Franz, A., Henneke, P., Debatin, K.-M., Schneiderhan-Marra, N., Janda, A., Elling, R.
10.1101/2021.07.20.21260863 — Posted: 2021-07-22 Discussion: Onsite
Validation and performance evaluation of a novel interferon-γ release assay for the detection of SARS-CoV-2 specific T-cell response
Huzly, D., Panning, M., Smely, F., Enders, M., Komp, J., Steinmann, D.
10.1101/2021.07.17.21260316 — Posted: 2021-07-22
Integrative Metabolomic and Proteomic Signatures Define Clinical Outcomes in Severe COVID-19
Alvarez-Mulett, S., Buyukozkan, M., Racanelli, A. C., Schmidt, F., Batra, R., Hoffman, K. L., Sarwath, H., Engelke, R., Gomez-Escobar, L., Simmons, W., Benedetti, E., Chetnik, K., Schenck, E., Suhre, K., Choi, J. J., Zhao, Z., Racine-Brzostek, S., Yang, H. S., Choi, M. E., Choi, A. M. K., Cho, S. J., Krumsiek, J.
10.1101/2021.07.19.21260776 — Posted: 2021-07-22
Antibody titers measured by commercial assays are correlated with neutralizing antibody titers calibrated by international standards
Kung, Y.-A., Huang, C.-G., Huang, S.-Y., Liu, K.-T., Huang, P.-N., Yu, K.-Y., Yang, S.-L., Chen, C.-P., Cheng, C.-Y., Lin, Y.-T., Liu, Y.-C., Chen, G.-W., Shih, S.-R.
10.1101/2021.07.16.21260618 — Posted: 2021-07-22
The efficacy of vaccines in the context of COVID-19 and its variants: Role of Spatio-temporal boundary
Roy, D., Chakravortty, D., Basu, S.
10.1101/2021.07.19.21260758 — Posted: 2021-07-22
Plasma cell-free DNA promise disease monitoring and tissue injury assessment of COVID-19
Jin, X., Wang, Y., Xu, J., Li, Y., Cheng, F., Luo, Y., Zhou, H., Lin, S., Xiao, F., Zhang, L., Lin, Y., Zhang, Z., Jin, Y., Zheng, F., Chen, W., Zhu, A., Tao, Y., Zhao, J., Kuo, T., Li, Y., Li, L., Wen, L., Ou, R., Li, F., Lin, L., Zhang, Y., Sun, J., Yuan, H., Zhuang, Z., Sun, H., Chen, Z., Li, J., Zhuo, J., Chen, D., Zhang, S., Sun, Y., Wei, P., Yuan, J., Xu, T., Yang, H., Wang, J., Xu, X., Zhong, N., Xu, Y., Sun, K., Zhao, J.
10.1101/2021.07.19.21260139 — Posted: 2021-07-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).